Picture of Chimerix logo

CMRX — Chimerix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Chimerix Inc reports results for the quarter ended in June - Earnings Summary

* Chimerix Inc  CMRX.OQ  reported a quarterly adjusted loss
of 27
cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 24 cents per share.
    * Revenue rose 12.5% to $440.00 thousand from a year ago;
analysts
expected $20.20 thousand. 
    * Chimerix Inc's reported EPS for the quarter was a loss
of 27
cents​.
    * The mean earnings estimate of analysts had fallen by
about 174.5% in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Chimerix Inc shares had risen by 28.8% this quarter and
lost 58.3% so far this year.
    * The company reported a quarterly loss of $23.47 million.
    * Wall Street's median 12-month price target for Chimerix
Inc is
$8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 8
at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.24          -0.27          Missed
 Mar. 31 2022      -0.33          -0.28          Beat
 Dec. 31 2021      -0.17          -0.45          Missed
 Sep. 30 2021      -0.15          -0.21          Missed

Recent news on Chimerix

See all news